logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Sangamo BioSciences (SGMO) Hits 10-Year High on Deal with Biogen (BIIB)

By  +Follow January 9, 2014 12:51PM
Share:
Tickers Mentioned:

Shares in Richmond, CA-based clinical stage biopharmaceutical company Sangamo BioSciences (SGMO) spiked nearly 35 percent on Thursday on news of a partnership with Biogen Idec (BIIB) to develop treatments for disorders affecting hemoglobin.

Biogen made an initial payment of $20 million to Sangamo as part of a deal that will total some $300 million in funding as well as double-digit royalties for Sangamo.

Lucrative Deal Drives SGMO to 10-Year High

On the whole, the size and generosity of the deal appear to make this a major win for Sangamo.

"The deal terms are very lucrative for a pre-clinical platform,” said Wedbush analyst Liana Moussatos. “So I think Biogen must have been impressed with the pre-clinical data that Sangamo presented last month."

The spike drove Sangamo to close to $19 a share, its highest level since 2001. It also passed the previous five-year high the company reached when shares were touching $18.50 in 2007.

Hemoglobin Disorders Affect Blood’s Ability to Carry Oxygen

Hemoglobin is the component of blood that carries oxygen, and disorders affecting hemoglobin include sickle cell disease and beta thalassemia. Both are very serious conditions and included in the category known as hemoglobinopathies.

Sangamo has developed technology to replace defective genes in patients with a corrective one, and Biogen appears to believe that this method has the potential to create one treatment for both diseases.

Sangamo will be responsible for research and development of the treatment up to the initial proof-of-concept trial.

SGMO Product Pipeline Could Have Potential

While Thursday’s announced partnership clearly took Sangamo to new levels, boosting the company’s market cap from $843.57 million to almost $1.15 billion in a matter of hours, the company has several treatments in its product pipeline that could also be major developments.

Most notable is lead therapy SB-728, which has the potential to develop into a functional cure for HIV/AIDS. The treatment would function by drawing immune cells, removing the protein pathway used by HIV to infect them, and then returning them to the patient’s bloodstream.

Sangamo’s promise appears to have won over investors, with the stock jumping over 130 percent despite the company failing to turn a profit and garnering revenues under $25 million in each of the last five years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for SGMO
Market Int Center
22 Aug 14 09:22:33
Potential Sangamo Biosciences $SGMO Trade Has 24.11% Downside Protection ( http://t.co/ItVB3UELLh )
Zachary Cary
21 Aug 14 10:07:57
RT @psuvafan007: #CRISPR Meet #genetherapy: #adenovirus #nonintegrating $BLUE $AGTC $AAVL $SGMO et al http://t.co/k4adZcfdjR
KiesenBiker
21 Aug 14 09:54:36
RT @psuvafan007: #CRISPR Meet #genetherapy: #adenovirus #nonintegrating $BLUE $AGTC $AAVL $SGMO et al http://t.co/k4adZcfdjR
Dr. Zoidberg
21 Aug 14 09:52:16
#CRISPR Meet #genetherapy: #adenovirus #nonintegrating $BLUE $AGTC $AAVL $SGMO et al http://t.co/k4adZcfdjR
Stocks in News
21 Aug 14 09:46:23
$SGMO: Top News: ChipMOS TECHNOLOGIES (NASDAQ:IMOS), Sangamo Biosciences ... http://t.co/4DLowpoYNA http://t.co/4E5KdcnKxJ
Daily Contracts
21 Aug 14 08:48:01
Real-Time feed of company contracts, original agreements and executive updates from Sangamo BioSciences, Inc. $SGMO http://t.co/C1HQWKnvja
Walter Live Oak
21 Aug 14 07:42:34
RT @FonsieTrader: Parabolic Sar Sell Signals 2/2 $LXRX $NBIX $NOR $OPK $PCLN $PKD $RGSE $ROSE $SFY $SGMO $SPLS $VDSI $WLT $YOKU http://t.c…
Lisa Nett
21 Aug 14 07:27:12
RT @myrollingstocks: We are watching $SGMO http://t.co/dbPdhjEAda
Myrollingstocks
21 Aug 14 07:25:09
We are watching $SGMO http://t.co/dbPdhjEAda
FonsieTrader
21 Aug 14 05:13:55
Parabolic Sar Sell Signals 2/2 $LXRX $NBIX $NOR $OPK $PCLN $PKD $RGSE $ROSE $SFY $SGMO $SPLS $VDSI $WLT $YOKU http://t.co/Bcszfxg6cr
Day Trader
20 Aug 14 15:19:06
AFTER HOURS : $SGMO $SMTC
Kevin Kennedy
20 Aug 14 14:38:13
RT @MarketCurrents: After Hour Gainers / Losers http://t.co/9hWOufSLQi $SMTC $SGMO $TTS $REXX
MarketCurrents
20 Aug 14 14:35:48
After Hour Gainers / Losers http://t.co/9hWOufSLQi $SMTC $SGMO $TTS $REXX
Biz News Pioneer
19 Aug 14 09:46:25
$SGMO: Grading Sobek's Mid-Year Biotech Stock Predictions http://t.co/VZfABZC2Ou http://t.co/Ix3ItbiJmK
Market Int Center
19 Aug 14 09:14:33
Sangamo Biosciences $SGMO Trading Near $13.85 Support Level ( http://t.co/3D4tIgqs85 )
Dan Wessler
18 Aug 14 20:36:18
Tuesday watch list: $AKS $BLUE $JRJC $PSDV $ARWR $AGIO $SGMO $ACRX $ANAC $GOOG $GILD
Lucretia
18 Aug 14 14:30:57
$SGMO Sangamo BioSciences Announces Presentation At The 2014 Wedbush ... http://t.co/cIMtpnDcTV
T Touch
18 Aug 14 07:06:36
good start to the week! $ACHN $KNDI $SGMO $SPPI
StockConsultant.com
18 Aug 14 07:05:35
$SGMO moving into the resistance gap http://t.co/PdYtD1U4Jb http://t.co/oCmEg35fGU
Biz Headlines
17 Aug 14 20:46:09
$SGMO: Will Sangamo (SGMO) Continue to Surge Higher? http://t.co/lCLquSpPx4 http://t.co/Q0Fkktjcna
US Banking News
17 Aug 14 19:35:23
Insider Selling: Sangamo Biosciences CEO Sells 25,000 Shares of Stock $SGMO http://t.co/dles5uubWJ
Stock Signaling
17 Aug 14 16:01:09
After Hours Price Advances: $RHI $OMER $DB $BLUE $SDRL $WB $AGN $ARO $MDT $NG $ICE $LTS $TSRO $SGMO $ARWR http://t.co/3gvJLENZtD #daytrading
US Banking News
15 Aug 14 19:44:24
Sangamo Biosciences CEO Edward O. Lanphier II Sells 25,000 Shares $SGMO http://t.co/vpmkZA28M9
Ticker Report
15 Aug 14 19:28:00
Sangamo Biosciences CEO Edward O. Lanphier II Sells 25,000 Shares $SGMO http://t.co/kT9B5RgMFO
$Stocknewsalerts
15 Aug 14 17:15:37
$SGMO New SEC Document(s) for Sangamo BioSciences, Inc. From our Stock News Alerts App
Stock News Guru
15 Aug 14 10:46:18
$SGMO: Sangamo Biosciences Coverage Initiated at JPMorgan Chase & Co. (SGMO) http://t.co/9iiq2Qldxk http://t.co/IeVlXd7o4k
John Turner
15 Aug 14 10:00:21
$SGMO Sangamo BioSciences Announces Presentation At The 2014 Wedbush ... http://t.co/2RIzjnceXZ
John Ablemann
15 Aug 14 10:00:20
$SGMO Top Stocks: Sangamo Biosciences Inc. (NASDAQ:SGMO), http://t.co/ltiVxMhzwm Inc. (NYSE ... http://t.co/r7xgiXpJY5
j
15 Aug 14 09:36:54
RT @OptionCast: Highest Put/Call ratios today $SGMO $WMB $CTIC $ARNA http://t.co/oMQu6xhajv
OptionCast
15 Aug 14 08:07:12
Highest Put/Call ratios today $SGMO $WMB $CTIC $ARNA http://t.co/oMQu6xhajv
Peter Bardens
15 Aug 14 06:31:07
$SGMO Sangamo BioSciences Announces Presentation At The 2014 Wedbush ... http://t.co/hA8OtZHjrO
				
				
By  +Follow January 9, 2014 12:51PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.